Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| BLLN | Tsao David | Chief Technology Officer | 09/24/2026 | Verkauf | 125.00 | 3,333 | 416,625 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 09/24/2026 | Verkauf | 120.00 | 1,416 | 169,920 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 09/21/2026 | Verkauf | 106.61 | 1,416 | 150,960 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/17/2026 | Verkauf | 110.29 | 5,840 | 644,112 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/17/2026 | Verkauf | 110.31 | 2,920 | 322,100 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/17/2026 | Verkauf | 110.30 | 6,968 | 768,561 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/17/2026 | Verkauf | 110.36 | 19,384 | 2,139,193 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 98.00 | 2,666 | 261,268 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 101.49 | 3,143 | 318,989 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 100.78 | 2,010 | 202,559 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 99.57 | 1,500 | 149,352 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 98.64 | 1,680 | 165,708 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 101.44 | 7,214 | 731,793 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 100.58 | 2,531 | 254,570 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 99.57 | 2,456 | 244,547 | Form 4 |
| BLLN | Atay Oguzhan | Chairman and CEO | 09/14/2026 | Verkauf | 98.63 | 4,465 | 440,389 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 09/09/2026 | Verkauf | 100.00 | 10,000 | 1,000,000 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 09/09/2026 | Verkauf | 97.54 | 1,416 | 138,117 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.92 | 232 | 23,414 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.20 | 2,518 | 252,293 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 98.89 | 576 | 56,960 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 101.41 | 147 | 14,907 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.33 | 1,131 | 113,469 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 99.22 | 385 | 38,201 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.82 | 358 | 36,095 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.11 | 2,997 | 300,040 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 99.00 | 614 | 60,785 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.83 | 775 | 78,142 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 100.12 | 8,285 | 829,517 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 98.97 | 1,944 | 192,390 | Form 4 |
| BLLN | Lynch Thomas P. | See Remarks | 09/08/2026 | Verkauf | 96.47 | 38 | 3,666 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 08/25/2026 | Verkauf | 100.00 | 10,000 | 1,000,000 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 08/25/2026 | Verkauf | 100.00 | 1,417 | 141,700 | Form 4 |
| BLLN | ten Bosch John Roderick | SVP of Laboratory Operations | 08/10/2026 | Verkauf | 92.86 | 1,417 | 131,583 | Form 4 |
| BLLN | Tsao David | Chief Technology Officer | 08/10/2026 | Verkauf | 92.86 | 10,000 | 928,600 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).